{ "responseHeader":{ "status":0, "QTime":0, "params":{ "q":"iati_identifier:XM-DAC-301-2-110299-001", "fl":"*", "format":"json" } }, "response":{ "numFound":1, "start":0, "numFoundExact":true, "docs":[{ "last-updated-datetime":"2026-02-13T18:59:49Z", "last_updated_datetime":"Fri Feb 13 18:59:49 UTC 2026", "last_updated_datetime_f":"2026-02-13T18:59:49Z", "lang":"en", "default_lang":"en", "iati-identifier":"XM-DAC-301-2-110299-001", "iati_identifier":"XM-DAC-301-2-110299-001", "reporting-org.type":"15", "reporting_org_type_code":"15", "reporting-org.ref":"XM-DAC-301-2", "reporting_org_ref":"XM-DAC-301-2", "reporting-org.narrative":["International Development Research Centre","Centre de recherches pour le développement international","Centro Internacional de Investigaciones para el Desarrollo"], "reporting_org_narrative":["International Development Research Centre","Centre de recherches pour le développement international","Centro Internacional de Investigaciones para el Desarrollo"], "reporting-org.narrative.lang":["en","fr","es"], "title.narrative":["Phase II polyvalent vaccine for freshwater catfish (Pangasius)","Vaccin polyvalent pour le poisson-chat d’eau douce (pangasius) – Phase II"], "title_narrative":["Phase II polyvalent vaccine for freshwater catfish (Pangasius)","Vaccin polyvalent pour le poisson-chat d’eau douce (pangasius) – Phase II"], "title_narrative_text":["Phase II polyvalent vaccine for freshwater catfish (Pangasius)","Vaccin polyvalent pour le poisson-chat d’eau douce (pangasius) – Phase II"], "title.narrative.lang":["en","fr"], "title_narrative_lang":["en","fr"], "description.type":["1"], "description_type":["1"], "description.narrative":["Vietnam is the global market leader in producing farmed freshwater catfish species known as Pangasius. Production has intensified, reaching 1.5 million tonnes in 2021 with an estimated value of USD1.7 billion (CAD2.21B). However, intensification has increased the prevalence and transmission of infections, resulting in up to 90% fish mortalities within affected farms. Vaccine hesitancy remains high, with Vietnamese Pangasius farmers choosing to administer a cocktail of antibiotics. The over-use of antibiotics has contributed to a rapid increase in antimicrobial resistance (AMR), resulting in mass fish mortalities and subsequent treatment failures. This aquatic food production sector has reached an AMR crisis point and urgently needs an alternative to antibiotics. \n\nA whole-cell inactivated vaccine has been developed for freshwater catfish and administered by immersion to give greater than 70% protection against two major pathogens during vaccination and efficacy trials. This project will advance the proof-of-concept polyvalent immersion vaccine through the development pipeline, increase vaccine uptake and provide the Pangasius farmers with an attractive alternative to antibiotics that they are willing to use. This interdisciplinary project will adopt state-of-the-art methods to address vaccine hesitancy in the fish farming communities, determine duration and level of protection in the target fish species, and develop laboratory-based assays to monitor successful vaccination.\n\nThis project is funded under InnoVet-AMR 2.0, a four-year partnership between IDRC and the UK’s Department of Health and Social Care. The initiative is aimed at reducing the emerging risk that anti-microbial resistance (AMR) in animals poses to global health and food security. ","Le Vietnam est le leader mondial de la production de poissons-chats d’eau douce d’élevage, connus sous le nom de pangasius. La production s’est intensifiée, atteignant 1,5 million de tonnes en 2021 pour une valeur estimée à 1,7 milliard USD (2,21 milliards CAD). Cependant, l’intensification a augmenté la prévalence et la transmission des infections, entraînant une mortalité des poissons pouvant aller jusqu’à 90 % dans les exploitations touchées. Les petites exploitations de pangasius au Vietnam préfèrent administrer un cocktail d’antibiotiques. L’utilisation excessive d’antibiotiques a contribué à l’augmentation rapide de la résistance aux antimicrobiens (RAM), entraînant des mortalités massives de poissons et l’échec des traitements qui s’ensuivent. Ce secteur de la production alimentaire aquatique a atteint un point critique en matière de résistance aux antimicrobiens et a besoin de toute urgence d’une solution de rechange aux antibiotiques. \n\nUn vaccin inactivé à cellules entières a été mis au point pour le poisson-chat d’eau douce et administré par immersion pour conférer une protection supérieure à 70 % contre deux pathogènes majeurs au cours d’essais de vaccination et d’efficacité. Ce projet permettra de faire progresser le vaccin polyvalent par immersion, dont le concept a fait ses preuves, dans la filière de développement, d’augmenter l’utilisation du vaccin et de fournir aux petites exploitations de pangasius une solution de rechange attrayante aux antibiotiques qui sont habituellement utilisés. Ce projet interdisciplinaire adoptera des méthodes de pointe pour lutter contre l’hésitation des communautés piscicoles à utiliser le vaccin, pour déterminer la durée et le niveau de protection des espèces de poissons ciblées et pour mettre au point des essais en laboratoire permettant de contrôler la réussite de la vaccination.\n\nCe projet est financé dans le cadre de l’initiative Solutions vétérinaires innovatrices pour la résistance aux antimicrobiens 2.0 (InnoVet-AMR 2.0), un partenariat de quatre ans entre le CRDI et le Department of Health and Social Care du Royaume-Uni. L’initiative vise à réduire les risques émergents que pose la résistance aux antimicrobiens chez les animaux pour la santé mondiale et la sécurité alimentaire. "], "description_narrative":["Vietnam is the global market leader in producing farmed freshwater catfish species known as Pangasius. Production has intensified, reaching 1.5 million tonnes in 2021 with an estimated value of USD1.7 billion (CAD2.21B). However, intensification has increased the prevalence and transmission of infections, resulting in up to 90% fish mortalities within affected farms. Vaccine hesitancy remains high, with Vietnamese Pangasius farmers choosing to administer a cocktail of antibiotics. The over-use of antibiotics has contributed to a rapid increase in antimicrobial resistance (AMR), resulting in mass fish mortalities and subsequent treatment failures. This aquatic food production sector has reached an AMR crisis point and urgently needs an alternative to antibiotics. \n\nA whole-cell inactivated vaccine has been developed for freshwater catfish and administered by immersion to give greater than 70% protection against two major pathogens during vaccination and efficacy trials. This project will advance the proof-of-concept polyvalent immersion vaccine through the development pipeline, increase vaccine uptake and provide the Pangasius farmers with an attractive alternative to antibiotics that they are willing to use. This interdisciplinary project will adopt state-of-the-art methods to address vaccine hesitancy in the fish farming communities, determine duration and level of protection in the target fish species, and develop laboratory-based assays to monitor successful vaccination.\n\nThis project is funded under InnoVet-AMR 2.0, a four-year partnership between IDRC and the UK’s Department of Health and Social Care. The initiative is aimed at reducing the emerging risk that anti-microbial resistance (AMR) in animals poses to global health and food security. ","Le Vietnam est le leader mondial de la production de poissons-chats d’eau douce d’élevage, connus sous le nom de pangasius. La production s’est intensifiée, atteignant 1,5 million de tonnes en 2021 pour une valeur estimée à 1,7 milliard USD (2,21 milliards CAD). Cependant, l’intensification a augmenté la prévalence et la transmission des infections, entraînant une mortalité des poissons pouvant aller jusqu’à 90 % dans les exploitations touchées. Les petites exploitations de pangasius au Vietnam préfèrent administrer un cocktail d’antibiotiques. L’utilisation excessive d’antibiotiques a contribué à l’augmentation rapide de la résistance aux antimicrobiens (RAM), entraînant des mortalités massives de poissons et l’échec des traitements qui s’ensuivent. Ce secteur de la production alimentaire aquatique a atteint un point critique en matière de résistance aux antimicrobiens et a besoin de toute urgence d’une solution de rechange aux antibiotiques. \n\nUn vaccin inactivé à cellules entières a été mis au point pour le poisson-chat d’eau douce et administré par immersion pour conférer une protection supérieure à 70 % contre deux pathogènes majeurs au cours d’essais de vaccination et d’efficacité. Ce projet permettra de faire progresser le vaccin polyvalent par immersion, dont le concept a fait ses preuves, dans la filière de développement, d’augmenter l’utilisation du vaccin et de fournir aux petites exploitations de pangasius une solution de rechange attrayante aux antibiotiques qui sont habituellement utilisés. Ce projet interdisciplinaire adoptera des méthodes de pointe pour lutter contre l’hésitation des communautés piscicoles à utiliser le vaccin, pour déterminer la durée et le niveau de protection des espèces de poissons ciblées et pour mettre au point des essais en laboratoire permettant de contrôler la réussite de la vaccination.\n\nCe projet est financé dans le cadre de l’initiative Solutions vétérinaires innovatrices pour la résistance aux antimicrobiens 2.0 (InnoVet-AMR 2.0), un partenariat de quatre ans entre le CRDI et le Department of Health and Social Care du Royaume-Uni. L’initiative vise à réduire les risques émergents que pose la résistance aux antimicrobiens chez les animaux pour la santé mondiale et la sécurité alimentaire. "], "description_narrative_text":["Vietnam is the global market leader in producing farmed freshwater catfish species known as Pangasius. Production has intensified, reaching 1.5 million tonnes in 2021 with an estimated value of USD1.7 billion (CAD2.21B). However, intensification has increased the prevalence and transmission of infections, resulting in up to 90% fish mortalities within affected farms. Vaccine hesitancy remains high, with Vietnamese Pangasius farmers choosing to administer a cocktail of antibiotics. The over-use of antibiotics has contributed to a rapid increase in antimicrobial resistance (AMR), resulting in mass fish mortalities and subsequent treatment failures. This aquatic food production sector has reached an AMR crisis point and urgently needs an alternative to antibiotics. \n\nA whole-cell inactivated vaccine has been developed for freshwater catfish and administered by immersion to give greater than 70% protection against two major pathogens during vaccination and efficacy trials. This project will advance the proof-of-concept polyvalent immersion vaccine through the development pipeline, increase vaccine uptake and provide the Pangasius farmers with an attractive alternative to antibiotics that they are willing to use. This interdisciplinary project will adopt state-of-the-art methods to address vaccine hesitancy in the fish farming communities, determine duration and level of protection in the target fish species, and develop laboratory-based assays to monitor successful vaccination.\n\nThis project is funded under InnoVet-AMR 2.0, a four-year partnership between IDRC and the UK’s Department of Health and Social Care. The initiative is aimed at reducing the emerging risk that anti-microbial resistance (AMR) in animals poses to global health and food security. ","Le Vietnam est le leader mondial de la production de poissons-chats d’eau douce d’élevage, connus sous le nom de pangasius. La production s’est intensifiée, atteignant 1,5 million de tonnes en 2021 pour une valeur estimée à 1,7 milliard USD (2,21 milliards CAD). Cependant, l’intensification a augmenté la prévalence et la transmission des infections, entraînant une mortalité des poissons pouvant aller jusqu’à 90 % dans les exploitations touchées. Les petites exploitations de pangasius au Vietnam préfèrent administrer un cocktail d’antibiotiques. L’utilisation excessive d’antibiotiques a contribué à l’augmentation rapide de la résistance aux antimicrobiens (RAM), entraînant des mortalités massives de poissons et l’échec des traitements qui s’ensuivent. Ce secteur de la production alimentaire aquatique a atteint un point critique en matière de résistance aux antimicrobiens et a besoin de toute urgence d’une solution de rechange aux antibiotiques. \n\nUn vaccin inactivé à cellules entières a été mis au point pour le poisson-chat d’eau douce et administré par immersion pour conférer une protection supérieure à 70 % contre deux pathogènes majeurs au cours d’essais de vaccination et d’efficacité. Ce projet permettra de faire progresser le vaccin polyvalent par immersion, dont le concept a fait ses preuves, dans la filière de développement, d’augmenter l’utilisation du vaccin et de fournir aux petites exploitations de pangasius une solution de rechange attrayante aux antibiotiques qui sont habituellement utilisés. Ce projet interdisciplinaire adoptera des méthodes de pointe pour lutter contre l’hésitation des communautés piscicoles à utiliser le vaccin, pour déterminer la durée et le niveau de protection des espèces de poissons ciblées et pour mettre au point des essais en laboratoire permettant de contrôler la réussite de la vaccination.\n\nCe projet est financé dans le cadre de l’initiative Solutions vétérinaires innovatrices pour la résistance aux antimicrobiens 2.0 (InnoVet-AMR 2.0), un partenariat de quatre ans entre le CRDI et le Department of Health and Social Care du Royaume-Uni. L’initiative vise à réduire les risques émergents que pose la résistance aux antimicrobiens chez les animaux pour la santé mondiale et la sécurité alimentaire. "], "description.narrative.lang":["en","fr"], "description_narrative_lang":["en","fr"], "participating-org.role":["4","1","1","2","3"], "participating_org_role":["4","1","1","2","3"], "participating-org.type":["80","10","10","80","15"], "participating_org_type":["80","10","10","80","15"], "participating-org.narrative":["University of Stirling","Canada. Parliament","Canada. Parlement","Canadá. Parlamento","United Kingdom. Department of Health and Social Care","University of Stirling","International Development Research Centre","Centre de recherches pour le développement international"], "participating_org_narrative":["University of Stirling","Canada. Parliament","Canada. Parlement","Canadá. Parlamento","United Kingdom. Department of Health and Social Care","University of Stirling","International Development Research Centre","Centre de recherches pour le développement international"], "participating_org_narrative_text":["University of Stirling","Canada. Parliament","Canada. Parlement","Canadá. Parlamento","United Kingdom. Department of Health and Social Care","University of Stirling","International Development Research Centre","Centre de recherches pour le développement international"], "participating-org.narrative.lang":["en","en","fr","es","en","en","en","fr"], "participating_org_narrative_lang":["en","en","fr","es","en","en","en","fr"], "participating-org.ref":["XM-DAC-301-2","GB-GOV-10","XM-DAC-301-2"], "participating_org_ref":["XM-DAC-301-2","GB-GOV-10","XM-DAC-301-2"], "participating-org.activity-id":["GB-GOV-10-GAMRIF-WP3-Inno-Vet-AMR"], "activity-status.code":"2", "activity_status_code":"2", "activity-date.iso-date":["2024-01-01T00:00:00Z","2027-01-01T00:00:00Z"], "activity_date_iso_date":["2024-01-01T00:00:00Z","2027-01-01T00:00:00Z"], "activity-date.type":["2","3"], "activity_date_type":["2","3"], "contact-info.type":["1"], "contact_info_type":["1"], "contact-info.organisation.narrative":["International Development Research Centre","Centre de recherches pour le développement international"], "contact_info_organisation_narrative":["International Development Research Centre","Centre de recherches pour le développement international"], "contact_info_organisation_narrative_text":["International Development Research Centre","Centre de recherches pour le développement international"], "contact-info.organisation.narrative.lang":["en","fr"], "contact_info_organisation_narrative_lang":["en","fr"], "contact-info.telephone":["(+1) 613-236-6163"], "contact_info_telephone":["(+1) 613-236-6163"], "contact-info.email":["info@idrc.ca"], "contact_info_email":["info@idrc.ca"], "contact-info.website":["http://www.idrc.ca"], "contact_info_website":["http://www.idrc.ca"], "contact-info.mailing-address.narrative":["PO Box 8500, Ottawa ON Canada, K1G 3H9","CP 8500, Ottawa ON Canada, K1G 3H9"], "contact_info_mailing_address_narrative":["PO Box 8500, Ottawa ON Canada, K1G 3H9","CP 8500, Ottawa ON Canada, K1G 3H9"], "contact_info_mailing_address_narrative_text":["PO Box 8500, Ottawa ON Canada, K1G 3H9","CP 8500, Ottawa ON Canada, K1G 3H9"], "contact-info.mailing-address.narrative.lang":["en","fr"], "contact_info_mailing_address_narrative_lang":["en","fr"], "activity-scope.code":"4", "activity_scope_code":"4", "recipient-country.code":["VN"], "recipient_country_code":["VN"], "recipient-country.percentage":[100.0], "recipient_country_percentage":[100.0], "sector.vocabulary":["1"], "sector_vocabulary":["1"], "sector.code":["31182"], "sector_code":["31182"], "sector.percentage":[100.0], "sector_percentage":[100.0], "policy-marker.vocabulary":["1","1","1","1","1","1","1","1","1"], "policy_marker_vocabulary":["1","1","1","1","1","1","1","1","1"], "policy-marker.code":["1","2","3","4","5","6","7","8","9"], "policy_marker_code":["1","2","3","4","5","6","7","8","9"], "policy-marker.significance":["0","0","0","0","0","0","0","0","0"], "policy_marker_significance":["0","0","0","0","0","0","0","0","0"], "collaboration-type.code":"1", "collaboration_type_code":"1", "default-flow-type.code":"10", "default_flow_type_code":"10", "default-finance-type.code":"110", "default_finance_type_code":"110", "default-aid-type.code":["C01"], "default_aid_type":["C01"], "default_aid_type_category_code":["C01"], "default_aid_type_code":["C01"], "default-tied-status.code":"5", "default_tied_status_code":"5", "budget.status":["2","2","2"], "budget_status":["2","2","2"], "budget.type":["2","1","2"], "budget_type":["2","1","2"], "budget.period-start.iso-date":["2024-04-01T00:00:00Z","2023-04-01T00:00:00Z","2025-04-01T00:00:00Z"], "budget_period_start_iso_date":["2024-04-01T00:00:00Z","2023-04-01T00:00:00Z","2025-04-01T00:00:00Z"], "budget.period-end.iso-date":["2025-03-31T00:00:00Z","2024-03-31T00:00:00Z","2026-03-31T00:00:00Z"], "budget_period_end_iso_date":["2025-03-31T00:00:00Z","2024-03-31T00:00:00Z","2026-03-31T00:00:00Z"], "budget.value":[0.0,877700.0,446100.0], "budget_value":[0.0,877700.0,446100.0], "budget.value.currency":["CAD","CAD","CAD"], "budget_value_currency":["CAD","CAD","CAD"], "budget.value.value-date":["2025-03-31T00:00:00Z","2024-03-31T00:00:00Z","2026-03-31T00:00:00Z"], "budget_value_date":["2025-03-31T00:00:00Z","2024-03-31T00:00:00Z","2026-03-31T00:00:00Z"], "planned-disbursement.type":["1","1","1","1","1"], "planned_disbursement_type":["1","1","1","1","1"], "planned-disbursement.period-start.iso-date":["2027-04-01T00:00:00Z","2026-04-01T00:00:00Z","2025-04-01T00:00:00Z","2024-04-01T00:00:00Z","2023-04-01T00:00:00Z"], "planned_disbursement_period_start_iso_date":["2027-04-01T00:00:00Z","2026-04-01T00:00:00Z","2025-04-01T00:00:00Z","2024-04-01T00:00:00Z","2023-04-01T00:00:00Z"], "planned-disbursement.period-end.iso-date":["2028-03-31T00:00:00Z","2027-03-31T00:00:00Z","2026-03-31T00:00:00Z","2025-03-31T00:00:00Z","2024-03-31T00:00:00Z"], "planned_disbursement_period_end_iso_date":["2028-03-31T00:00:00Z","2027-03-31T00:00:00Z","2026-03-31T00:00:00Z","2025-03-31T00:00:00Z","2024-03-31T00:00:00Z"], "planned-disbursement.value":[66190.0,305644.0,436005.0,343761.0,172200.0], "planned_disbursement_value":[66190.0,305644.0,436005.0,343761.0,172200.0], "planned-disbursement.provider-org.type":["15","15","15","15","15"], "planned_disbursement_provider_org_type":["15","15","15","15","15"], "planned-disbursement.provider-org.ref":["XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2"], "planned_disbursement_provider_org_ref":["XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2"], "planned-disbursement.provider-org.narrative":["International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international"], "planned_disbursement_provider_org_narrative":["International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international"], "planned_disbursement_provider_org_narrative_text":["International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international"], "planned-disbursement.provider-org.narrative.lang":["en","fr","en","fr","en","fr","en","fr","en","fr"], "planned_disbursement_provider_org_narrative_lang":["en","fr","en","fr","en","fr","en","fr","en","fr"], "planned-disbursement.receiver-org.type":["80","80","80","80","80"], "planned_disbursement_receiver_org_type":["80","80","80","80","80"], "planned-disbursement.receiver-org.narrative":["University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling"], "planned_disbursement_receiver_org_narrative":["University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling"], "planned_disbursement_receiver_org_narrative_text":["University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling"], "planned-disbursement.receiver-org.narrative.lang":["en","en","en","en","en"], "planned_disbursement_receiver_org_narrative_lang":["en","en","en","en","en"], "planned-disbursement.value.currency":["CAD","CAD","CAD","CAD","CAD"], "planned_disbursement_value_currency":["CAD","CAD","CAD","CAD","CAD"], "planned-disbursement.value.value-date":["2027-04-01T00:00:00Z","2026-04-01T00:00:00Z","2025-04-01T00:00:00Z","2024-04-01T00:00:00Z","2023-04-01T00:00:00Z"], "planned_disbursement_value_date":["2027-04-01T00:00:00Z","2026-04-01T00:00:00Z","2025-04-01T00:00:00Z","2024-04-01T00:00:00Z","2023-04-01T00:00:00Z"], "transaction.transaction-type.code":["3","3","3","2","2","2","11","11"], "transaction_type":["3","3","3","2","2","2","11","11"], "transaction.transaction-date.iso-date":["2025-06-30T00:00:00Z","2024-12-31T00:00:00Z","2025-09-30T00:00:00Z","2025-06-30T00:00:00Z","2024-12-31T00:00:00Z","2025-09-30T00:00:00Z","2024-03-31T00:00:00Z","2024-03-31T00:00:00Z"], "transaction_date_iso_date":["2025-06-30T00:00:00Z","2024-12-31T00:00:00Z","2025-09-30T00:00:00Z","2025-06-30T00:00:00Z","2024-12-31T00:00:00Z","2025-09-30T00:00:00Z","2024-03-31T00:00:00Z","2024-03-31T00:00:00Z"], "transaction.value":[130361.0,385600.0,130360.0,130361.0,385600.0,130360.0,333726.24,543973.76], "transaction_value":[130361.0,385600.0,130360.0,130361.0,385600.0,130360.0,333726.24,543973.76], "transaction.description.narrative":["Disbursement","Décaissement","Disbursement","Décaissement","Disbursement","Décaissement","Outgoing Commitment","Engagement sortant","Outgoing Commitment","Engagement sortant","Outgoing Commitment","Engagement sortant","Incoming Commitment","Engagement entrant","Incoming Commitment","Engagement entrant"], "transaction_description_narrative":["Disbursement","Décaissement","Disbursement","Décaissement","Disbursement","Décaissement","Outgoing Commitment","Engagement sortant","Outgoing Commitment","Engagement sortant","Outgoing Commitment","Engagement sortant","Incoming Commitment","Engagement entrant","Incoming Commitment","Engagement entrant"], "transaction.description.narrative.lang":["en","fr","en","fr","en","fr","en","fr","en","fr","en","fr","en","fr","en","fr"], "transaction_description_lang":["en","fr","en","fr","en","fr","en","fr","en","fr","en","fr","en","fr","en","fr"], "transaction.provider-org.type":["15","15","15","15","15","15","15","10"], "transaction_provider_org_type":["15","15","15","15","15","15","15","10"], "transaction.provider-org.ref":["XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","GB-GOV-10"], "transaction_provider_org_ref":["XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","XM-DAC-301-2","GB-GOV-10"], "transaction.provider-org.narrative":["International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","Canada. Parliament","Canada. Parlement","Canadá. Parlamento","United Kingdom. Department of Health and Social Care"], "transaction_provider_org_narrative":["International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","Canada. Parliament","Canada. Parlement","Canadá. Parlamento","United Kingdom. Department of Health and Social Care"], "transaction_provider_org_narrative_text":["International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international","Canada. Parliament","Canada. Parlement","Canadá. Parlamento","United Kingdom. Department of Health and Social Care"], "transaction.provider-org.narrative.lang":["en","fr","en","fr","en","fr","en","fr","en","fr","en","fr","en","fr","es","en"], "transaction_provider_org_narrative_lang":["en","fr","en","fr","en","fr","en","fr","en","fr","en","fr","en","fr","es","en"], "transaction.receiver-org.type":["80","80","80","80","80","80","15","15"], "transaction_receiver_org_type_code":["80","80","80","80","80","80","15","15"], "transaction.receiver-org.narrative":["University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international"], "transaction_receiver_org_narrative":["University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international"], "transaction_receiver_org_narrative_text":["University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling","University of Stirling","International Development Research Centre","Centre de recherches pour le développement international","International Development Research Centre","Centre de recherches pour le développement international"], "transaction.receiver-org.narrative.lang":["en","en","en","en","en","en","en","fr","en","fr"], "transaction_receiver_org_narrative_lang":["en","en","en","en","en","en","en","fr","en","fr"], "transaction.disbursement-channel.code":["2","2","2","2","2","2","2","2"], "transaction_disbursement_channel_code":["2","2","2","2","2","2","2","2"], "transaction.value.currency":["CAD","CAD","CAD","CAD","CAD","CAD","CAD","CAD"], "transaction_value_currency":["CAD","CAD","CAD","CAD","CAD","CAD","CAD","CAD"], "transaction.value.value-date":["2025-06-30T00:00:00Z","2024-12-31T00:00:00Z","2025-09-30T00:00:00Z","2025-06-30T00:00:00Z","2024-12-31T00:00:00Z","2025-09-30T00:00:00Z","2024-03-31T00:00:00Z","2024-03-31T00:00:00Z"], "transaction_value_date":["2025-06-30T00:00:00Z","2024-12-31T00:00:00Z","2025-09-30T00:00:00Z","2025-06-30T00:00:00Z","2024-12-31T00:00:00Z","2025-09-30T00:00:00Z","2024-03-31T00:00:00Z","2024-03-31T00:00:00Z"], "transaction.receiver-org.ref":["XM-DAC-301-2","XM-DAC-301-2"], "transaction_receiver_org_ref":["XM-DAC-301-2","XM-DAC-301-2"], "transaction.provider-org.provider-activity-id":["GB-GOV-10-GAMRIF-WP3-Inno-Vet-AMR"], "transaction_provider_org_provider_activity_id":["GB-GOV-10-GAMRIF-WP3-Inno-Vet-AMR"], "related-activity.ref":["XM-DAC-301-2-110299-003"], "related_activity_ref":["XM-DAC-301-2-110299-003"], "related-activity.type":["3"], "related_activity_type":["3"], "conditions.attached":false, "conditions_attached":"0", "reporting-org.type.name":"Other Public Sector", "reporting_org_type_name":"Other Public Sector", "recipient-country.name":["Viet Nam"], "recipient_country_name":["Viet Nam"], "default-aid-type.name":["Project-type interventions"], "default_aid_type_category_name":["Project-type interventions"], "policy-marker.name":["Gender Equality","Aid to Environment","Participatory Development/Good Governance","Trade Development","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Reproductive, Maternal, Newborn and Child Health (RMNCH)"], "policy-marker.significance.name":["not targeted","not targeted","not targeted","not targeted","not targeted","not targeted","not targeted","not targeted","not targeted"], "policy-marker.vocabulary.name":["OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS"], "budget.type.name":["Revised","Original","Revised"], "budget.status.name":["Committed","Committed","Committed"], "transaction.receiver-org.type.name":["Academic, Training and Research","Academic, Training and Research","Academic, Training and Research","Academic, Training and Research","Academic, Training and Research","Academic, Training and Research","Other Public Sector","Other Public Sector"], "transaction_receiver_org_type_name":["Academic, Training and Research","Academic, Training and Research","Academic, Training and Research","Academic, Training and Research","Academic, Training and Research","Academic, Training and Research","Other Public Sector","Other Public Sector"], "title.narrative.first":"Phase II polyvalent vaccine for freshwater catfish (Pangasius)", "title_narrative_first":"Phase II polyvalent vaccine for freshwater catfish (Pangasius)", "activity-date.start-actual":"2024-01-01T00:00:00Z", "activity_date_start_actual":"Mon Jan 01 00:00:00 UTC 2024", "activity_date_start_actual_f":"2024-01-01T00:00:00Z", "activity-date.common.start":"2024-01-01T00:00:00Z", "activity_date_start_common":"Mon Jan 01 00:00:00 UTC 2024", "activity_date_start_common_f":"2024-01-01T00:00:00Z", "activity-date.end-planned":"2027-01-01T00:00:00Z", "activity_date_end_planned":"Fri Jan 01 00:00:00 UTC 2027", "activity_date_end_planned_f":"2027-01-01T00:00:00Z", "activity-date.common.end":"2027-01-01T00:00:00Z", "activity_date_end_common":"Fri Jan 01 00:00:00 UTC 2027", "activity_date_end_common_f":"2027-01-01T00:00:00Z", "activity-status.text":"Implementation", "activity_status_text":"Implementation", "policy-marker.combined":["1__0","2__0","3__0","4__0","5__0","6__0","7__0","8__0","9__0"], "policy_marker_combined":["1__0","2__0","3__0","4__0","5__0","6__0","7__0","8__0","9__0"], "budget.value-usd":[0.0], "budget_value_usd":[0.0], "budget.value-usd.sum":0.0, "budget_value_usd_sum":0.0, "budget.value-usd.conversion-rate":[1.4428004009759603], "budget_usd_conversion_rate":[1.4428004009759603], "budget.value-usd.conversion-currency":["CAD"], "budget.value-gbp":[0.0], "budget_value_gbp":[0.0], "budget.value-gbp.sum":0.0, "budget_value_gbp_sum":0.0, "budget.value-gbp.conversion-rate":[1.8266573357795388], "budget_gbp_conversion_rate":[1.8266573357795388], "budget.value-gbp.conversion-currency":["CAD"], "planned-disbursement.value-usd":[47659.84440558486,220077.73807977914,127687.04778740602], "planned_disbursement_value_usd":[47659.84440558486,220077.73807977914,127687.04778740602], "planned-disbursement.value-usd.sum":395424.63027277, "planned_disbursement_value_usd_sum":395424.63027277, "planned-disbursement.value-usd.conversion-rate":[1.3888001697345813,1.3888001697345813,1.3486097688365881], "planned_disbursement_usd_conversion_rate":[1.3888001697345813,1.3888001697345813,1.3486097688365881], "planned-disbursement.value-usd.conversion-currency":["CAD"], "planned-disbursement.value-gbp":[35830.42435895464,165453.30446847458,102573.67563254571], "planned_disbursement_value_gbp":[35830.42435895464,165453.30446847458,102573.67563254571], "planned-disbursement.value-gbp.sum":303857.40445997496, "planned_disbursement_value_gbp_sum":303857.40445997496, "planned-disbursement.value-gbp.conversion-rate":[1.8473127568040644,1.8473127568040644,1.6787933057686244], "planned_disbursement_gbp_conversion_rate":[1.8473127568040644,1.8473127568040644,1.6787933057686244], "planned-disbursement.value-gbp.conversion-currency":["CAD"], "transaction.value-usd.sum":379289.1856910944, "transaction_value_usd_sum":379289.1856910944, "transaction.value-usd.conversion-rate":[1.3706990139862487,1.3789003142658627,1.3706990139862487,1.3789003142658627], "transaction_usd_conversion_rate":[1.3706990139862487,1.3789003142658627,1.3706990139862487,1.3789003142658627], "transaction.value-usd.conversion-currency":["CAD"], "transaction.value-gbp.sum":281930.57743257517, "transaction_value_gbp_sum":281930.57743257517, "transaction.value-gbp.conversion-rate":[1.8546926121716554,1.8444167440249004,1.8546926121716554,1.8444167440249004], "transaction_gbp_conversion_rate":[1.8546926121716554,1.8444167440249004,1.8546926121716554,1.8444167440249004], "transaction.value-gbp.conversion-currency":["CAD"], "dataset.id":"a2a61343-2f15-490c-86a4-37d26da68931", "dataset_iati_id":"a2a61343-2f15-490c-86a4-37d26da68931", "dataset.name":"idrccrdi-act-active", "dataset_name":"idrccrdi-act-active", "dataset.extras.iati_version":"2.03", "dataset.resources.hash":"b7aa385e30c35aef471ba874cdf83e2bc6f033a2", "dataset.resources.url":"https://idrc-crdi.ca/sites/default/files/2026-03/idrc_iati_activities_Active_2025-04-01_2025-12-31.xml", "hierarchy":1, "activity-date.quarter":[1,1], "budget.period-start.quarter":[2,2,2], "budget.period-end.quarter":[1,1,1], "planned-disbursement.period-start.quarter":[2,2,2,2,2], "planned-disbursement.period-end.quarter":[1,1,1,1,1], "transaction.transaction-date.quarter":[2,4,3,2,4,3,1,1], "transaction.value-usd":[95105.48900220322,94539.10384334397,95105.48900220322,94539.10384334397], "transaction_value_usd":[95105.48900220322,94539.10384334397,95105.48900220322,94539.10384334397], "transaction.value-usd-type":[3,3,3,2,2,2,11,11], "transaction.value-gbp":[70287.11881661112,70678.16989967648,70287.11881661112,70678.16989967648], "transaction_value_gbp":[70287.11881661112,70678.16989967648,70287.11881661112,70678.16989967648], "transaction.value-gbp-type":[3,3,3,2,2,2,11,11], "activity-aggregation.budget.value":1323800.0, "activity_aggregation_budget_value":1323800.0, "activity-aggregation.budget.value-usd":0.0, "activity_aggregation_budget_value_usd":0.0, "activity-aggregation.budget.value-gbp":0.0, "activity_aggregation_budget_value_gbp":0.0, "activity-aggregation.budget.currency":"CAD", "activity_aggregation_budget_currency":"CAD", "activity-aggregation.planned-disbursement.value":1323800.0, "activity-aggregation.planned-disbursement.value-usd":395424.63027277, "activity-aggregation.planned-disbursement.value-gbp":303857.40445997496, "activity-aggregation.planned-disbursement.currency":"CAD", "activity-aggregation.outgoing-commitment.value":646321.0, "activity_aggregation_commitment_value":646321.0, "activity-aggregation.outgoing-commitment.value-usd":189644.5928455472, "activity_aggregation_commitment_value_usd":189644.5928455472, "activity-aggregation.outgoing-commitment.value-gbp":140965.28871628758, "activity_aggregation_commitment_value_gbp":140965.28871628758, "activity-aggregation.disbursement.value":646321.0, "activity_aggregation_disbursement_value":646321.0, "activity-aggregation.disbursement.value-usd":189644.5928455472, "activity_aggregation_disbursement_value_usd":189644.5928455472, "activity-aggregation.disbursement.value-gbp":140965.28871628758, "activity_aggregation_disbursement_value_gbp":140965.28871628758, "activity-aggregation.incoming-commitment.value":877700.0, "activity_aggregation_incoming_commitment_value":877700.0, "activity-aggregation.incoming-commitment.value-usd":0.0, "activity_aggregation_incoming_commitment_value_usd":0.0, "activity-aggregation.incoming-commitment.value-gbp":0.0, "activity_aggregation_incoming_commitment_value_gbp":0.0, "json.reporting-org":"{\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\", \"Centro Internacional de Investigaciones para el Desarrollo\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\", \"es\"]}", "json.title":"{\"narrative\": [\"Phase II polyvalent vaccine for freshwater catfish (Pangasius)\", \"Vaccin polyvalent pour le poisson-chat d\\u2019eau douce (pangasius) \\u2013 Phase II\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}", "json.description":["{\"type\": 1, \"narrative\": [\"Vietnam is the global market leader in producing farmed freshwater catfish species known as Pangasius. Production has intensified, reaching 1.5 million tonnes in 2021 with an estimated value of USD1.7 billion (CAD2.21B). However, intensification has increased the prevalence and transmission of infections, resulting in up to 90% fish mortalities within affected farms. Vaccine hesitancy remains high, with Vietnamese Pangasius farmers choosing to administer a cocktail of antibiotics. The over-use of antibiotics has contributed to a rapid increase in antimicrobial resistance (AMR), resulting in mass fish mortalities and subsequent treatment failures. This aquatic food production sector has reached an AMR crisis point and urgently needs an alternative to antibiotics. \\n\\nA whole-cell inactivated vaccine has been developed for freshwater catfish and administered by immersion to give greater than 70% protection against two major pathogens during vaccination and efficacy trials. This project will advance the proof-of-concept polyvalent immersion vaccine through the development pipeline, increase vaccine uptake and provide the Pangasius farmers with an attractive alternative to antibiotics that they are willing to use. This interdisciplinary project will adopt state-of-the-art methods to address vaccine hesitancy in the fish farming communities, determine duration and level of protection in the target fish species, and develop laboratory-based assays to monitor successful vaccination.\\n\\nThis project is funded under InnoVet-AMR 2.0, a four-year partnership between IDRC and the UK\\u2019s Department of Health and Social Care. The initiative is aimed at reducing the emerging risk that anti-microbial resistance (AMR) in animals poses to global health and food security. \", \"Le Vietnam est le leader mondial de la production de poissons-chats d\\u2019eau douce d\\u2019\\u00e9levage, connus sous le nom de pangasius. La production s\\u2019est intensifi\\u00e9e, atteignant 1,5 million de tonnes en 2021 pour une valeur estim\\u00e9e \\u00e0 1,7 milliard USD (2,21 milliards CAD). Cependant, l\\u2019intensification a augment\\u00e9 la pr\\u00e9valence et la transmission des infections, entra\\u00eenant une mortalit\\u00e9 des poissons pouvant aller jusqu\\u2019\\u00e0 90 % dans les exploitations touch\\u00e9es. Les petites exploitations de pangasius au Vietnam pr\\u00e9f\\u00e8rent administrer un cocktail d\\u2019antibiotiques. L\\u2019utilisation excessive d\\u2019antibiotiques a contribu\\u00e9 \\u00e0 l\\u2019augmentation rapide de la r\\u00e9sistance aux antimicrobiens (RAM), entra\\u00eenant des mortalit\\u00e9s massives de poissons et l\\u2019\\u00e9chec des traitements qui s\\u2019ensuivent. Ce secteur de la production alimentaire aquatique a atteint un point critique en mati\\u00e8re de r\\u00e9sistance aux antimicrobiens et a besoin de toute urgence d\\u2019une solution de rechange aux antibiotiques. \\n\\nUn vaccin inactiv\\u00e9 \\u00e0 cellules enti\\u00e8res a \\u00e9t\\u00e9 mis au point pour le poisson-chat d\\u2019eau douce et administr\\u00e9 par immersion pour conf\\u00e9rer une protection sup\\u00e9rieure \\u00e0 70 % contre deux pathog\\u00e8nes majeurs au cours d\\u2019essais de vaccination et d\\u2019efficacit\\u00e9. Ce projet permettra de faire progresser le vaccin polyvalent par immersion, dont le concept a fait ses preuves, dans la fili\\u00e8re de d\\u00e9veloppement, d\\u2019augmenter l\\u2019utilisation du vaccin et de fournir aux petites exploitations de pangasius une solution de rechange attrayante aux antibiotiques qui sont habituellement utilis\\u00e9s. Ce projet interdisciplinaire adoptera des m\\u00e9thodes de pointe pour lutter contre l\\u2019h\\u00e9sitation des communaut\\u00e9s piscicoles \\u00e0 utiliser le vaccin, pour d\\u00e9terminer la dur\\u00e9e et le niveau de protection des esp\\u00e8ces de poissons cibl\\u00e9es et pour mettre au point des essais en laboratoire permettant de contr\\u00f4ler la r\\u00e9ussite de la vaccination.\\n\\nCe projet est financ\\u00e9 dans le cadre de l\\u2019initiative Solutions v\\u00e9t\\u00e9rinaires innovatrices pour la r\\u00e9sistance aux antimicrobiens 2.0 (InnoVet-AMR 2.0), un partenariat de quatre ans entre le CRDI et le Department of Health and Social Care du Royaume-Uni. L\\u2019initiative vise \\u00e0 r\\u00e9duire les risques \\u00e9mergents que pose la r\\u00e9sistance aux antimicrobiens chez les animaux pour la sant\\u00e9 mondiale et la s\\u00e9curit\\u00e9 alimentaire. \"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}"], "json.participating-org":["{\"role\": 4, \"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}","{\"role\": 1, \"type\": 10, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"Canada. Parliament\", \"Canada. Parlement\", \"Canad\\u00e1. Parlamento\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\", \"es\"]}","{\"role\": 1, \"type\": 10, \"ref\": \"GB-GOV-10\", \"activity-id\": \"GB-GOV-10-GAMRIF-WP3-Inno-Vet-AMR\", \"narrative\": \"United Kingdom. Department of Health and Social Care\", \"narrative.lang\": \"en\"}","{\"role\": 2, \"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}","{\"role\": 3, \"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}"], "json.activity-date":["{\"iso-date\": \"2024-01-01\", \"type\": 2}","{\"iso-date\": \"2027-01-01\", \"type\": 3}"], "json.contact-info":["{\"type\": 1, \"organisation\": {\"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"telephone\": \"(+1) 613-236-6163\", \"email\": \"info@idrc.ca\", \"website\": \"http://www.idrc.ca\", \"mailing-address\": {\"narrative\": [\"PO Box 8500, Ottawa ON Canada, K1G 3H9\", \"CP 8500, Ottawa ON Canada, K1G 3H9\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}}"], "json.recipient-country":["{\"code\": \"VN\", \"percentage\": 100}"], "json.sector":["{\"vocabulary\": 1, \"code\": 31182, \"percentage\": 100}"], "json.policy-marker":["{\"vocabulary\": 1, \"code\": 1, \"significance\": 0}","{\"vocabulary\": 1, \"code\": 2, \"significance\": 0}","{\"vocabulary\": 1, \"code\": 3, \"significance\": 0}","{\"vocabulary\": 1, \"code\": 4, \"significance\": 0}","{\"vocabulary\": 1, \"code\": 5, \"significance\": 0}","{\"vocabulary\": 1, \"code\": 6, \"significance\": 0}","{\"vocabulary\": 1, \"code\": 7, \"significance\": 0}","{\"vocabulary\": 1, \"code\": 8, \"significance\": 0}","{\"vocabulary\": 1, \"code\": 9, \"significance\": 0}"], "json.default-aid-type":["{\"code\": \"C01\"}"], "json.budget":["{\"status\": 2, \"type\": 2, \"period-start\": [{\"iso-date\": \"2024-04-01\"}], \"period-end\": [{\"iso-date\": \"2025-03-31\"}], \"value\": 0.0, \"value.currency\": \"CAD\", \"value.value-date\": \"2025-03-31\"}","{\"status\": 2, \"type\": 1, \"period-start\": [{\"iso-date\": \"2023-04-01\"}], \"period-end\": [{\"iso-date\": \"2024-03-31\"}], \"value\": 877700.0, \"value.currency\": \"CAD\", \"value.value-date\": \"2024-03-31\"}","{\"status\": 2, \"type\": 2, \"period-start\": [{\"iso-date\": \"2025-04-01\"}], \"period-end\": [{\"iso-date\": \"2026-03-31\"}], \"value\": 446100.0, \"value.currency\": \"CAD\", \"value.value-date\": \"2026-03-31\"}"], "json.planned-disbursement":["{\"type\": 1, \"period-start\": [{\"iso-date\": \"2027-04-01\"}], \"period-end\": [{\"iso-date\": \"2028-03-31\"}], \"value\": 66190.0, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"value.currency\": \"CAD\", \"value.value-date\": \"2027-04-01\"}","{\"type\": 1, \"period-start\": [{\"iso-date\": \"2026-04-01\"}], \"period-end\": [{\"iso-date\": \"2027-03-31\"}], \"value\": 305644.0, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"value.currency\": \"CAD\", \"value.value-date\": \"2026-04-01\"}","{\"type\": 1, \"period-start\": [{\"iso-date\": \"2025-04-01\"}], \"period-end\": [{\"iso-date\": \"2026-03-31\"}], \"value\": 436005.0, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"value.currency\": \"CAD\", \"value.value-date\": \"2025-04-01\"}","{\"type\": 1, \"period-start\": [{\"iso-date\": \"2024-04-01\"}], \"period-end\": [{\"iso-date\": \"2025-03-31\"}], \"value\": 343761.0, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"value.currency\": \"CAD\", \"value.value-date\": \"2024-04-01\"}","{\"type\": 1, \"period-start\": [{\"iso-date\": \"2023-04-01\"}], \"period-end\": [{\"iso-date\": \"2024-03-31\"}], \"value\": 172200.0, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"value.currency\": \"CAD\", \"value.value-date\": \"2023-04-01\"}"], "json.transaction":["{\"transaction-type\": {\"code\": 3}, \"transaction-date\": {\"iso-date\": \"2025-06-30\"}, \"value\": 130361.0, \"description\": {\"narrative\": [\"Disbursement\", \"D\\u00e9caissement\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"disbursement-channel\": {\"code\": 2}, \"value.currency\": \"CAD\", \"value.value-date\": \"2025-06-30\"}","{\"transaction-type\": {\"code\": 3}, \"transaction-date\": {\"iso-date\": \"2024-12-31\"}, \"value\": 385600.0, \"description\": {\"narrative\": [\"Disbursement\", \"D\\u00e9caissement\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"disbursement-channel\": {\"code\": 2}, \"value.currency\": \"CAD\", \"value.value-date\": \"2024-12-31\"}","{\"transaction-type\": {\"code\": 3}, \"transaction-date\": {\"iso-date\": \"2025-09-30\"}, \"value\": 130360.0, \"description\": {\"narrative\": [\"Disbursement\", \"D\\u00e9caissement\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"disbursement-channel\": {\"code\": 2}, \"value.currency\": \"CAD\", \"value.value-date\": \"2025-09-30\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2025-06-30\"}, \"value\": 130361.0, \"description\": {\"narrative\": [\"Outgoing Commitment\", \"Engagement sortant\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"disbursement-channel\": {\"code\": 2}, \"value.currency\": \"CAD\", \"value.value-date\": \"2025-06-30\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2024-12-31\"}, \"value\": 385600.0, \"description\": {\"narrative\": [\"Outgoing Commitment\", \"Engagement sortant\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"disbursement-channel\": {\"code\": 2}, \"value.currency\": \"CAD\", \"value.value-date\": \"2024-12-31\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2025-09-30\"}, \"value\": 130360.0, \"description\": {\"narrative\": [\"Outgoing Commitment\", \"Engagement sortant\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"receiver-org\": {\"type\": 80, \"narrative\": \"University of Stirling\", \"narrative.lang\": \"en\"}, \"disbursement-channel\": {\"code\": 2}, \"value.currency\": \"CAD\", \"value.value-date\": \"2025-09-30\"}","{\"transaction-type\": {\"code\": 11}, \"transaction-date\": {\"iso-date\": \"2024-03-31\"}, \"value\": 333726.24, \"description\": {\"narrative\": [\"Incoming Commitment\", \"Engagement entrant\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"provider-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"Canada. Parliament\", \"Canada. Parlement\", \"Canad\\u00e1. Parlamento\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\", \"es\"]}, \"receiver-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"disbursement-channel\": {\"code\": 2}, \"value.currency\": \"CAD\", \"value.value-date\": \"2024-03-31\"}","{\"transaction-type\": {\"code\": 11}, \"transaction-date\": {\"iso-date\": \"2024-03-31\"}, \"value\": 543973.76, \"description\": {\"narrative\": [\"Incoming Commitment\", \"Engagement entrant\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"provider-org\": {\"type\": 10, \"provider-activity-id\": \"GB-GOV-10-GAMRIF-WP3-Inno-Vet-AMR\", \"ref\": \"GB-GOV-10\", \"narrative\": \"United Kingdom. Department of Health and Social Care\", \"narrative.lang\": \"en\"}, \"receiver-org\": {\"type\": 15, \"ref\": \"XM-DAC-301-2\", \"narrative\": [\"International Development Research Centre\", \"Centre de recherches pour le d\\u00e9veloppement international\"], \"narrative.currency\": [], \"narrative.value_date\": [], \"narrative.year\": [], \"narrative.lang\": [\"en\", \"fr\"]}, \"disbursement-channel\": {\"code\": 2}, \"value.currency\": \"CAD\", \"value.value-date\": \"2024-03-31\"}"], "json.related-activity":["{\"ref\": \"XM-DAC-301-2-110299-003\", \"type\": 3}"], "json.conditions":"{\"attached\": 0}", "related_budget_value":[0], "related_budget_period_start_quarter":[2], "related_budget_period_end_quarter":[1], "related_budget_period_start_iso_date":["2025-04-01T00:00:00Z"], "related_budget_period_end_iso_date":["2026-03-31T00:00:00Z"], "id":"c87a038d-255e-4952-af18-89aa1376cc94", "related_activity_context":"ID: XM-DAC-301-2-110299-001\nTitle: Phase II polyvalent vaccine for freshwater catfish (Pangasius). Vaccin polyvalent pour le poisson-chat d’eau douce (pangasius) – Phase II\nDescription: Vietnam is the global market leader in producing farmed freshwater catfish species known as Pangasius. Production has intensified, reaching 1.5 million tonnes in 2021 with an estimated value of USD1.7 billion (CAD2.21B). However, intensification has increased the prevalence and transmission of infections, resulting in up to 90% fish mortalities within affected farms. Vaccine hesitancy remains high, with Vietnamese Pangasius farmers choosing to administer a cocktail of antibiotics. The over-use of antibiotics has contributed to a rapid increase in antimicrobial resistance (AMR), resulting in mass fish mortalities and subsequent treatment failures. This aquatic food production sector has reached an AMR crisis point and urgently needs an alternative to antibiotics. \n\nA whole-cell inactivated vaccine has been developed for freshwater catfish and administered by immersion to give greater than 70% protection against two major pathogens during vaccination and efficacy trials. This project will advance the proof-of-concept polyvalent immersion vaccine through the development pipeline, increase vaccine uptake and provide the Pangasius farmers with an attractive alternative to antibiotics that they are willing to use. This interdisciplinary project will adopt state-of-the-art methods to address vaccine hesitancy in the fish farming communities, determine duration and level of protection in the target fish species, and develop laboratory-based assays to monitor successful vaccination.\n\nThis project is funded under InnoVet-AMR 2.0, a four-year partnership between IDRC and the UK’s Department of Health and Social Care. The initiative is aimed at reducing the emerging risk that anti-microbial resistance (AMR) in animals poses to global health and food security. . Le Vietnam est le leader mondial de la production de poissons-chats d’eau douce d’élevage, connus sous le nom de pangasius. La production s’est intensifiée, atteignant 1,5 million de tonnes en 2021 pour une valeur estimée à 1,7 milliard USD (2,21 milliards CAD). Cependant, l’intensification a augmenté la prévalence et la transmission des infections, entraînant une mortalité des poissons pouvant aller jusqu’à 90 % dans les exploitations touchées. Les petites exploitations de pangasius au Vietnam préfèrent administrer un cocktail d’antibiotiques. L’utilisation excessive d’antibiotiques a contribué à l’augmentation rapide de la résistance aux antimicrobiens (RAM), entraînant des mortalités massives de poissons et l’échec des traitements qui s’ensuivent. Ce secteur de la production alimentaire aquatique a atteint un point critique en matière de résistance aux antimicrobiens et a besoin de toute urgence d’une solution de rechange aux antibiotiques. \n\nUn vaccin inactivé à cellules entières a été mis au point pour le poisson-chat d’eau douce et administré par immersion pour conférer une protection supérieure à 70 % contre deux pathogènes majeurs au cours d’essais de vaccination et d’efficacité. Ce projet permettra de faire progresser le vaccin polyvalent par immersion, dont le concept a fait ses preuves, dans la filière de développement, d’augmenter l’utilisation du vaccin et de fournir aux petites exploitations de pangasius une solution de rechange attrayante aux antibiotiques qui sont habituellement utilisés. Ce projet interdisciplinaire adoptera des méthodes de pointe pour lutter contre l’hésitation des communautés piscicoles à utiliser le vaccin, pour déterminer la durée et le niveau de protection des espèces de poissons ciblées et pour mettre au point des essais en laboratoire permettant de contrôler la réussite de la vaccination.\n\nCe projet est financé dans le cadre de l’initiative Solutions vétérinaires innovatrices pour la résistance aux antimicrobiens 2.0 (InnoVet-AMR 2.0), un partenariat de quatre ans entre le CRDI et le Department of Health and Social Care du Royaume-Uni. L’initiative vise à réduire les risques émergents que pose la résistance aux antimicrobiens chez les animaux pour la santé mondiale et la sécurité alimentaire. \n \n ID: XM-DAC-301-2-110299-003\nTitle: Phase II polyvalent vaccine for freshwater catfish (Pangasius). Vaccin polyvalent pour le poisson-chat d’eau douce (pangasius) – Phase II\nDescription: Vietnam is the global market leader in producing farmed freshwater catfish species known as Pangasius. Production has intensified, reaching 1.5 million tonnes in 2021 with an estimated value of USD1.7 billion (CAD2.21B). However, intensification has increased the prevalence and transmission of infections, resulting in up to 90% fish mortalities within affected farms. Vaccine hesitancy remains high, with Vietnamese Pangasius farmers choosing to administer a cocktail of antibiotics. The over-use of antibiotics has contributed to a rapid increase in antimicrobial resistance (AMR), resulting in mass fish mortalities and subsequent treatment failures. This aquatic food production sector has reached an AMR crisis point and urgently needs an alternative to antibiotics. \n\nA whole-cell inactivated vaccine has been developed for freshwater catfish and administered by immersion to give greater than 70% protection against two major pathogens during vaccination and efficacy trials. This project will advance the proof-of-concept polyvalent immersion vaccine through the development pipeline, increase vaccine uptake and provide the Pangasius farmers with an attractive alternative to antibiotics that they are willing to use. This interdisciplinary project will adopt state-of-the-art methods to address vaccine hesitancy in the fish farming communities, determine duration and level of protection in the target fish species, and develop laboratory-based assays to monitor successful vaccination.\n\nThis project is funded under InnoVet-AMR 2.0, a four-year partnership between IDRC and the UK’s Department of Health and Social Care. The initiative is aimed at reducing the emerging risk that anti-microbial resistance (AMR) in animals poses to global health and food security. . Le Vietnam est le leader mondial de la production de poissons-chats d’eau douce d’élevage, connus sous le nom de pangasius. La production s’est intensifiée, atteignant 1,5 million de tonnes en 2021 pour une valeur estimée à 1,7 milliard USD (2,21 milliards CAD). Cependant, l’intensification a augmenté la prévalence et la transmission des infections, entraînant une mortalité des poissons pouvant aller jusqu’à 90 % dans les exploitations touchées. Les petites exploitations de pangasius au Vietnam préfèrent administrer un cocktail d’antibiotiques. L’utilisation excessive d’antibiotiques a contribué à l’augmentation rapide de la résistance aux antimicrobiens (RAM), entraînant des mortalités massives de poissons et l’échec des traitements qui s’ensuivent. Ce secteur de la production alimentaire aquatique a atteint un point critique en matière de résistance aux antimicrobiens et a besoin de toute urgence d’une solution de rechange aux antibiotiques. \n\nUn vaccin inactivé à cellules entières a été mis au point pour le poisson-chat d’eau douce et administré par immersion pour conférer une protection supérieure à 70 % contre deux pathogènes majeurs au cours d’essais de vaccination et d’efficacité. Ce projet permettra de faire progresser le vaccin polyvalent par immersion, dont le concept a fait ses preuves, dans la filière de développement, d’augmenter l’utilisation du vaccin et de fournir aux petites exploitations de pangasius une solution de rechange attrayante aux antibiotiques qui sont habituellement utilisés. Ce projet interdisciplinaire adoptera des méthodes de pointe pour lutter contre l’hésitation des communautés piscicoles à utiliser le vaccin, pour déterminer la durée et le niveau de protection des espèces de poissons ciblées et pour mettre au point des essais en laboratoire permettant de contrôler la réussite de la vaccination.\n\nCe projet est financé dans le cadre de l’initiative Solutions vétérinaires innovatrices pour la résistance aux antimicrobiens 2.0 (InnoVet-AMR 2.0), un partenariat de quatre ans entre le CRDI et le Department of Health and Social Care du Royaume-Uni. L’initiative vise à réduire les risques émergents que pose la résistance aux antimicrobiens chez les animaux pour la santé mondiale et la sécurité alimentaire. \n", "_version_":1863491912032321536 }] } }